These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 2446073)
1. Effects of antagonists of 5-hydroxytryptamine on blood pressure in the anesthetised spontaneously hypertensive rat. Docherty JR; Warnock P J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S59-61. PubMed ID: 2446073 [TBL] [Abstract][Full Text] [Related]
2. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats. Docherty JR J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414 [TBL] [Abstract][Full Text] [Related]
3. Comparison between ketanserin and LY 53857 on vascular and cardiac 5-HT2 and alpha 1-adrenergic receptors in the pithed rat. Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H Arch Int Pharmacodyn Ther; 1990; 306():57-64. PubMed ID: 1981667 [TBL] [Abstract][Full Text] [Related]
5. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat. Cohen ML; Fuller RW; Kurz KD J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat. Persson B; Gradin K; Pettersson A; Hedner T J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S22-4. PubMed ID: 2459509 [TBL] [Abstract][Full Text] [Related]
7. Central 5-hydroxytryptamine (5-HT) receptors in blood pressure regulation. Dabiré H Therapie; 1991; 46(6):421-9. PubMed ID: 1819150 [TBL] [Abstract][Full Text] [Related]
8. Differences in the chronic hypotensive mechanism of action of ketanserin in spontaneously hypertensive and Wistar-Kyoto rats. Balasubramaniam G; Lee HS; Mah SC J Hypertens; 1994 Jan; 12(1):7-14. PubMed ID: 8157947 [TBL] [Abstract][Full Text] [Related]
9. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat. Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797 [TBL] [Abstract][Full Text] [Related]
10. Ketanserin: systemic and regional hemodynamic characterization of its serotonergic and alpha-adrenergic receptor blocking effects in the pithed SHR. Scalbert E; Richer C; Giudicelli JF J Cardiovasc Pharmacol; 1989 Jan; 13(1):94-104. PubMed ID: 2468942 [TBL] [Abstract][Full Text] [Related]
11. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors. Shen FM; Wang J; Ni CR; Yu JG; Wang WZ; Su DF Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):702-7. PubMed ID: 17600544 [TBL] [Abstract][Full Text] [Related]
12. Are drugs that act both on serotonin receptors and alpha 1-adrenoceptors more potent hypotensive agents than those that act only on alpha 1-adrenoceptors? Ramage AG J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S30-4. PubMed ID: 2459511 [TBL] [Abstract][Full Text] [Related]
13. Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat. McDaid J; Docherty JR Br J Pharmacol; 2001 Jun; 133(3):429-37. PubMed ID: 11375260 [TBL] [Abstract][Full Text] [Related]
14. Serotonin agonists and antagonists in experimental hypertension. Saxena PR; Bolt GR; Dhasmana KM J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S12-8. PubMed ID: 2446059 [TBL] [Abstract][Full Text] [Related]
15. Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats. Balasubramaniam G; Lee HS; Mah SC J Pharmacol Exp Ther; 1993 Jan; 264(1):129-34. PubMed ID: 8093720 [TBL] [Abstract][Full Text] [Related]
16. Differences in vasodilating action between ketanserin, a 5-HT2-serotonergic receptor antagonist, and terazosin, an alpha 1-adrenoceptor antagonist, in anesthetized rabbits. Ikeda K; Takata M; Tomoda F; Mikawa M; Iida H; Sasayama S J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S69-72. PubMed ID: 2446076 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of the effects of some 5-HT1A receptor agonists on the blood pressure of pithed rats. Castillo C; Bobadilla RA; Ibarra M; Castillo EF; Hong E Arch Med Res; 1995; 26(3):251-5. PubMed ID: 8580676 [TBL] [Abstract][Full Text] [Related]
18. Effects of urapidil on blood pressure and adrenoceptors in various animal models. van Zwieten PA; Mathy MJ; Thoolent MJ; Wilffert B; de Jonge A; Timmermans PB J Hypertens Suppl; 1984 Dec; 2(3):S539-41. PubMed ID: 6599713 [TBL] [Abstract][Full Text] [Related]
19. Blood pressure and alpha-vascular reactivity in hypertensive rats treated with amlodipine and dietary Ca. Civantos B; Aleixandre A Eur J Pharmacol; 2004 Apr; 489(1-2):101-10. PubMed ID: 15063161 [TBL] [Abstract][Full Text] [Related]
20. Effects of low-dose ketanserin on blood pressure variability, baroreflex sensitivity and end-organ damage in spontaneously hypertensive rats. Xie HH; Shen FM; Cao YB; Li HL; Su DF Clin Sci (Lond); 2005 Jun; 108(6):547-52. PubMed ID: 15707387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]